Our Supporters How to Participate in Precision Panc Remit of Scientific Advisory Board Meeting Minutes Membership Remit of Therapeutic Testing Board Meeting Minutes Precision Panc Therapeutic Testing Board Membership Remit of Steering Committee Patient Stories Steering Group Members Therapeutic Testing Board Meetings PRIMUS 002 PRIMUS 001 Working with the NHS Patient Public Engagement Meetings Steering Committee Scientific Advisory Board Governance Structure Governance Master Protocol Kick Off Meeting News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Research History Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Home | Team Members | Duncan Jodrell

Professor of Cancer Therapeutics

University of Cambridge

Duncan Jodrell

Professor of Cancer Therapeutics, University of Cambridge.
Senior Group Leader and Head of the Pharmacology and Drug Development Group at the Cancer Research UK Cambridge Institute.  
Cambridge Experimental Cancer Medicine Centre (ECMC) Lead for Early Phase Trials
Honorary consultant at Addenbrookes Hospital. 

Precision-Panc Grantholder

Duncan is a fully trained and accredited Medical Oncologist.  Since moving to Cambridge, he has been instrumental in establishing the specialist oncology clinic for patients with pancreatic cancer (in 2009), which, together with his research activity in cancer therapeutics were major factors in Cambridge’s successful application to become the Regional Centre for Pancreatic Cancer (in 2010).  As the Cambridge ECMC Lead for Early Phase Trials, he manages a research team and clinic, allowing patients across the Anglia region to access new therapies for cancer.

As a Senior Group Leader in the Cancer Research UK Cambridge Institute, Duncan undertakes research into new therapies for patients with cancer.  He also collaborates closely with imaging specialists in both the Institute and Addenbrookes Hospital, incorporating novel molecular imaging approaches into Early Phase trials of cancer therapeutics.

Co-Lead Pre-Clinical Therapeutics

Contributor: Research, Clinical Trials

Specialist knowledge: Clinical trials, experimental therapeutics, combination approaches, molecular imaging, pharmacokinetics

© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.